Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 296,683 | 222,503 | 286,326 | 28,003 | 31,340 |
| Marketable Securities | 86,644 | 57,812 | 0 | 123,716 | 125,201 |
| Receivables | 123,330 | 78,286 | 67,968 | 23,994 | 3,267 |
| Inventories | 24,887 | 22,403 | 22,312 | 5,565 | 1,513 |
| TOTAL | $549,684 | $392,788 | $387,541 | $190,225 | $166,592 |
| Non-Current Assets | |||||
| PPE Net | 1,862 | 1,139 | 706 | 914 | 981 |
| Investments And Advances | 8,105 | 12,526 | 0 | 0 | 4,983 |
| Intangibles | 260,921 | 249,819 | 252,925 | 58,954 | 18,740 |
| Other Non-Current Assets | 22,241 | 14,482 | 5,449 | 102,813 | 103,355 |
| TOTAL | $293,129 | $277,966 | $259,080 | $162,681 | $128,059 |
| Total Assets | $842,813 | $670,754 | $646,621 | $352,906 | $294,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,614 | 14,618 | 7,416 | 8,690 | 9,166 |
| Accrued Expenses | 196,185 | 111,933 | 78,544 | 54,018 | 30,723 |
| Other current liabilities | N/A | N/A | N/A | 1,090 | 1,996 |
| TOTAL | $205,799 | $126,551 | $87,064 | $64,729 | $42,596 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 322,324 | 318,563 | 310,887 | 146,140 | 131,843 |
| TOTAL | $322,324 | $318,563 | $310,887 | $146,140 | $131,843 |
| Total Liabilities | $528,123 | $445,114 | $397,951 | $210,869 | $174,439 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,342 | 49,014 | 47,003 | 37,951 | 31,730 |
| Common Shares | 5 | 5 | 5 | 4 | 3 |
| Retained earnings | -667,544 | -644,181 | -556,239 | -392,824 | -257,159 |
| Other shareholders' equity | 351 | -373 | 1,644 | -217 | -35 |
| TOTAL | $314,690 | $225,640 | $248,670 | $142,037 | $120,212 |
| Total Liabilities And Equity | $842,813 | $670,754 | $646,621 | $352,906 | $294,651 |